-transparent.png){kind=logo}
The synthesis and properties of the title compounds 1 are described. Many of these compounds are potent inhibitors of the passive cutaneous anaphylaxis reaction of rats against egg albumin challenge. Structural variations include substitutions in the 2, 3, 4, 5, 7, and 12 position of the nucleus 1. A novel rearrangement from a compound of the related [3,4-f] series to this group is reported.
Related Publications
J P Devlin, and
K Freter, and
P B Stewart
March 1978,
British journal of pharmacology,
J P Devlin, and
K Freter, and
P B Stewart
May 1978,
Journal of medicinal chemistry,
J P Devlin, and
K Freter, and
P B Stewart
April 2007,
The Journal of organic chemistry,
J P Devlin, and
K Freter, and
P B Stewart
September 2011,
Bioorganic & medicinal chemistry,
J P Devlin, and
K Freter, and
P B Stewart
January 1985,
Arzneimittel-Forschung,
J P Devlin, and
K Freter, and
P B Stewart
June 2001,
Bioorganic & medicinal chemistry letters,
J P Devlin, and
K Freter, and
P B Stewart
February 2004,
Bioorganic & medicinal chemistry,
J P Devlin, and
K Freter, and
P B Stewart
May 2009,
Bioorganic & medicinal chemistry letters,
J P Devlin, and
K Freter, and
P B Stewart
March 2007,
Medicinal chemistry (Shariqah (United Arab Emirates)),
J P Devlin, and
K Freter, and
P B Stewart
October 2017,
Molecules (Basel, Switzerland),
